FDA Inspection 851996 — Khozema Palanpurwala, MD

Khozema Palanpurwala, MD — FEI 3010253870

The FDA completed an inspection of Khozema Palanpurwala, MD on Nov 21, 2013 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 21, 2013
Fiscal Year
2014
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)